NCT03186209 Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Status COMPLETED Phase PHASE3
NCT03181880 To Evaluate Effectiveness of Aclidinium Bromide/Formoterol Fumarate Dihydrate in Chronic Obstructive Pulmonary Disease Status WITHDRAWN Phase PHASE4
NCT03180489 Does Dapagliflozin Provide Additional Health Benefits To Dietary Counseling For Weight Loss? Status COMPLETED Phase PHASE2
NCT03174275 Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03172702 Open-label Safety of Sodium Zirconium Cyclosilicate for up to 12 Months in Japanese Subjects With Hyperkalemia Status COMPLETED Phase PHASE3
NCT03171636 Frequency of EGFR and KRAS Mutations and Clinical-prognostic Correlation in Brazilian Lung Cancer Patients Status COMPLETED Phase N/A
NCT03170271 A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma. Status COMPLETED Phase PHASE3
NCT03169959 A Study to Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration. Status COMPLETED Phase PHASE1
NCT03167619 Phase II Multicenter Study of Durvalumab and Olaparib in Platinum tReated Advanced Triple Negative Breast Cancer (DORA) Status COMPLETED Phase PHASE2
NCT03164616 Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON). Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03162055 Efficacy and Safety of Glycopyrronium/Formoterol Fumarate Fixed-dose Combination Relative to Umeclidinium/Vilanterol Fixed-dose Combination Over 24 Weeks in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease Status COMPLETED Phase PHASE3
NCT03161132 Resistant Ovarian Cancer, Olaparib and Liposomal Doxorubicin Status COMPLETED Phase PHASE2
NCT03159442 Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Male Japanese Subjects Status COMPLETED Phase PHASE1
NCT03158064 Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03158038 Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2017-2018 Season Status COMPLETED Phase PHASE4
NCT03156998 Patients' Compliance to Home Nebulizer Therapy for Children's Asthma in China Status COMPLETED Phase N/A
NCT03156985 Multi-center, Single Arm, Observational Study to Evaluate the Safety of Dapagliflozin in Type 2 Diabetes Mellitus Patients in China Status COMPLETED Phase N/A
NCT03152084 The Study Will Evaluate Average 24-hr Sodium Excretion During Dapagliflozin Treatment in Patients With Type 2 Diabetes Mellitus With Preserved or Impaired Renal Function or Non-diabetics With Impaired Renal Function. Status TERMINATED Phase PHASE4